首页 | 本学科首页   官方微博 | 高级检索  
     

分化型甲状腺癌131I治疗后导致唾液腺功能障碍的相关研究进展
引用本文:董环欣,付鹏. 分化型甲状腺癌131I治疗后导致唾液腺功能障碍的相关研究进展[J]. 现代肿瘤医学, 2022, 0(11): 2102-2106. DOI: 10.3969/j.issn.1672-4992.2022.11.040
作者姓名:董环欣  付鹏
作者单位:哈尔滨医科大学附属第一医院核医学科,黑龙江 哈尔滨 150000
摘    要:131I治疗作为分化型甲状腺癌(differentiated thyroid cancer,DTC)常规治疗手段之一,其常见的毒副反应之一是唾液腺功能障碍。由于DTC患者生存期长,唾液腺功能障碍会影响患者的日常生活和心理健康,逐渐引起许多学者的担忧。了解131I治疗后导致的唾液腺功能障碍的机制、临床表现和诊治方法对于提高患者的生活质量至关重要。因此,本文对DTC患者131I治疗后导致的唾液腺功能障碍进行了系统的综述。

关 键 词:分化型甲状腺癌  131I治疗  唾液腺功能障碍

Research progress on salivary gland dysfunction after 131I therapy of differentiated thyroid cancer
DONG Huanxin,FU Peng. Research progress on salivary gland dysfunction after 131I therapy of differentiated thyroid cancer[J]. Journal of Modern Oncology, 2022, 0(11): 2102-2106. DOI: 10.3969/j.issn.1672-4992.2022.11.040
Authors:DONG Huanxin  FU Peng
Affiliation:Department of Nuclear Medicine,the First Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150000,China.
Abstract:As one of the routine treatment methods of differentiated thyroid cancer,one of the most common side effects of 131I therapy is salivary gland dysfunction.Because of the long survival period of DTC patients,the salivary gland dysfunction will affect the patients' daily life and mental health,which gradually caused many scholars' concern.It is very important to understand the mechanism,clinical manifestation,diagnosis and treatment of salivary gland dysfunction after 131I therapy.Therefore,this article systematically reviews the salivary gland dysfunction of DTC patients after 131I therapy.
Keywords:differentiated thyroid cancer   131I therapy   salivary gland dysfunction
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号